3 Patents
- 0 cites
- US120775542024CDK9 Inhibitors and Polymorphs Thereof for Use as Agents for Treatment of Cancer
Sumitomo Pharma Oncology, Inc.
0 cites - US116333952023Substituted Pyrazolo[1,5-a]pyrazines as Negative Allosteric Modulators of Group II Metabotropic Glutamate Receptor
SUMITOMO PHARMA CO., Ltd.
0 cites